These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 571341)
21. Dopaminergic-cholinergic interactions in naloxone-induced circling in morphine-dependent rats with nigral lesions. Iwamoto ET; Loh HH; Way EL Eur J Pharmacol; 1976 Jul; 38(1):39-54. PubMed ID: 986306 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of ciladopa hydrochloride as a potential anti-Parkinson drug. Koller WC; Fields JZ; Gordon JH; Perlow MJ Neuropharmacology; 1986 Sep; 25(9):973-9. PubMed ID: 3774130 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of apomorphine-induced behaviors by derivatives of 2-amino-1, 2, 3, 4-tetrahydronaphthalene. Rusterholz DB; Long JP; Flynn JR; Glyn JR; Barfknecht CF; Lind RW; Johnson AK Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):246-60. PubMed ID: 567044 [TBL] [Abstract][Full Text] [Related]
24. Dopamine receptors mediate drug-induced but not Pavlovian conditioned contralateral rotation in the unilateral 6-OHDA animal model. Carey RJ Brain Res; 1990 May; 515(1-2):292-8. PubMed ID: 2113414 [TBL] [Abstract][Full Text] [Related]
25. Pharmacological profile of N,N dipropyl-8-hydroxy-3-chromanamine, an oxygen isostere of the dopamine agonist N,N dipropyl-5-hydroxy-2-aminotetralin with enhanced presynaptic selectivity. Vermue NA; Kaptein B; Tepper PG; de Vries JB; Horn AS Arch Int Pharmacodyn Ther; 1988; 293():37-56. PubMed ID: 3421784 [TBL] [Abstract][Full Text] [Related]
26. Pharmacological evidence for the subclassification of central dopamine receptors in the rat. Gower AJ; Marriott AS Br J Pharmacol; 1982 Sep; 77(1):185-93. PubMed ID: 6889902 [TBL] [Abstract][Full Text] [Related]
27. Apomorphine stereotypies and transmitter mechanisms in the striatum. I. Changes in the apomorphine stereotypies caused by drugs acting on the GABA-ergic, dopaminergic and cholinergic transmission. Georgiev VP; Markovska VL; Petkova BP Acta Physiol Pharmacol Bulg; 1978; 4(3):56-64. PubMed ID: 220843 [TBL] [Abstract][Full Text] [Related]
28. Lack of potency of metoclopramide's metabolites in various dopaminergic models. Stanley M; Wazer D; Virgilio J; Kuhn CM; Benson DI; Meyerson LR Pharmacol Biochem Behav; 1983 Feb; 18(2):263-6. PubMed ID: 6682229 [TBL] [Abstract][Full Text] [Related]
29. Adenosine 3',5'-cyclic monophosphate as a possible mediator of rotational behaviour induced by dopaminergic receptor stimulation in rats lesioned unilaterally in the substantia nigra. Satoh H; Satoh Y; Notsu Y; Honda F Eur J Pharmacol; 1976 Oct; 39(2):365-77. PubMed ID: 185065 [TBL] [Abstract][Full Text] [Related]
30. Denervation in the dopaminergic mesolimbic system: functional changes followed using (-)N-n-propylnorapomorphine depend on the basal activity levels of rats. Costall B; Hui SC; Naylor RJ Neuropharmacology; 1980 Nov; 19(11):1039-48. PubMed ID: 7192370 [No Abstract] [Full Text] [Related]
31. Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats. Rosengarten H; Friedhoff AJ Science; 1979 Mar; 203(4385):1133-5. PubMed ID: 570724 [TBL] [Abstract][Full Text] [Related]
32. 6-Hydroxydopamine lesions of olfactory tubercles and caudate nuclei: effect on amphetamine-induced stereotyped behavior in rats. Asher IM; Aghajanian GK Brain Res; 1974 Dec; 82(1):1-12. PubMed ID: 4373138 [No Abstract] [Full Text] [Related]
33. Inhibition of nigral dopaminergic firing by N-n-propyl-norapomorphine: behavioural and biochemical correlates. Mereu G; Argiolas A; Melis MR; Gessa GL Ann Ist Super Sanita; 1982; 18(1):57-61. PubMed ID: 6892092 [No Abstract] [Full Text] [Related]
34. Drug-induced dopaminergic supersensitivity. Moore KE; Thornburg JE Adv Neurol; 1975; 9():93-104. PubMed ID: 1146661 [No Abstract] [Full Text] [Related]
35. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA. Johnson AM; Loew DM; Vigouret JM Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193 [TBL] [Abstract][Full Text] [Related]
36. Influence of dopaminergic agonists and antagonists on serum prolactin concentrations in the rat. Horowski R; Gräf HJ Neuroendocrinology; 1976; 22(3):273-86. PubMed ID: 1028957 [TBL] [Abstract][Full Text] [Related]
37. Quantitative microfluorimetry of formaldehyde induced fluorescence of dopamine in the caudate nucleus. Einarsson P; Hallman H; Jonsson G Med Biol; 1975 Feb; 53(1):15-24. PubMed ID: 238082 [TBL] [Abstract][Full Text] [Related]